Nova Leap Health Corp. (TSXV:NLH)
Canada · Delayed Price · Currency is CAD 0.5900
+0.0300 (5.36%)
Aug 26, 2026, 11:31 AM EST
Nova Leap Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.44 | 1.49 | 1.4 | 0.89 | 1.27 | 1.73 |
Cash & Short-Term Investments | 1.44 | 1.49 | 1.4 | 0.89 | 1.27 | 1.73 |
Cash Growth | 3.47% | 6.43% | 56.77% | -29.69% | -26.58% | -37.62% |
Accounts Receivable | 2.01 | 1.84 | 1.7 | 1.65 | 1.75 | 2.17 |
Other Receivables | - | - | - | - | 0.66 | 1.77 |
Receivables | 2.01 | 1.84 | 1.7 | 1.65 | 2.41 | 3.94 |
Prepaid Expenses | 0.42 | 0.26 | 0.32 | 0.29 | 0.29 | 0.29 |
Total Current Assets | 3.87 | 3.59 | 3.42 | 2.84 | 3.98 | 5.96 |
Property, Plant & Equipment | 0.99 | 0.91 | 0.98 | 1.19 | 1.49 | 1.29 |
Goodwill | 18.96 | 17.06 | 15.97 | 14.62 | 16.04 | 16.71 |
Other Intangible Assets | 1 | 0.55 | 0.63 | 0.54 | 1.09 | 2.08 |
Long-Term Deferred Tax Assets | 0.97 | 1.37 | 1.39 | 1.7 | 1.35 | 0.73 |
Total Assets | 25.8 | 23.48 | 22.39 | 20.9 | 23.95 | 26.77 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.81 | 1.38 | 1.49 | 1.18 | 1.23 | 1.31 |
Accrued Expenses | 0.08 | 0.09 | 0.07 | 0.06 | 0.01 | 0.21 |
Short-Term Debt | 3.04 | 1.79 | 1.21 | - | 1.38 | 3.12 |
Current Portion of Long-Term Debt | 0.17 | 0.13 | 0.11 | 0.21 | 0.98 | 0.87 |
Current Portion of Leases | 0.37 | 0.31 | 0.3 | 0.28 | 0.33 | 0.29 |
Current Income Taxes Payable | - | - | - | - | - | 0.2 |
Other Current Liabilities | 0.04 | 0.04 | 0.05 | 0.06 | 0.06 | 0.23 |
Total Current Liabilities | 5.51 | 3.73 | 3.24 | 1.78 | 3.99 | 6.23 |
Long-Term Debt | 0.23 | 0.09 | 0.22 | - | 0.12 | 0.9 |
Long-Term Leases | 0.64 | 0.62 | 0.68 | 0.91 | 1.16 | 1.02 |
Other Long-Term Liabilities | - | - | - | - | - | 0.14 |
Total Liabilities | 6.38 | 4.44 | 4.14 | 2.7 | 5.27 | 8.29 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 19.1 | 19.1 | 19.1 | 18.96 | 18.96 | 17.14 |
Additional Paid-In Capital | 2.46 | 2.42 | 2.31 | 2.26 | 2.13 | 1.78 |
Retained Earnings | -0.08 | -1.06 | -0.87 | -2.25 | -1.19 | -0.36 |
Comprehensive Income & Other | -2.06 | -1.42 | -2.3 | -0.78 | -1.22 | -0.08 |
Shareholders' Equity | 19.42 | 19.04 | 18.25 | 18.2 | 18.68 | 18.48 |
Total Liabilities & Equity | 25.8 | 23.48 | 22.39 | 20.9 | 23.95 | 26.77 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4.45 | 2.93 | 2.53 | 1.4 | 3.97 | 6.2 |
Net Cash (Debt) | -3.01 | -1.44 | -1.12 | -0.5 | -2.69 | -4.47 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.03 | -0.02 | -0.01 | -0.01 | -0.03 | -0.06 |
Filing Date Shares Outstanding | 87.31 | 87.31 | 87.31 | 86.21 | 86.21 | 79.29 |
Total Common Shares Outstanding | 87.31 | 87.31 | 87.31 | 86.21 | 86.21 | 79.29 |
Working Capital | -1.64 | -0.13 | 0.18 | 1.06 | -0.01 | -0.26 |
Book Value Per Share | 0.22 | 0.22 | 0.21 | 0.21 | 0.22 | 0.23 |
Tangible Book Value | -0.54 | 1.43 | 1.64 | 3.03 | 1.55 | -0.3 |
Tangible Book Value Per Share | -0.01 | 0.02 | 0.02 | 0.04 | 0.02 | -0.00 |